HER2-positive Advanced Breast With Liver Metastases
1 clinical trials · Condition
◉ Watch HER2-positive Advanced Breast With Liver Metastases
| Record | Firm | Date |
|---|---|---|
| A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases (NCT03500380) | RemeGen Co., Ltd. | 2018-04-24 |
Track HER2-positive Advanced Breast With Liver Metastases automatically
Every clearance here is in the API, with alerts when new ones post.